Invitae pulls in $120M to back Dx global expansion; NanoLogix reconfigures tests for Ebola virus;

> Genetic diagnostics firm Invitae said it raised $120 million in a series F financing round designed to help back the build-out of its infrastructure and expand globally. Story (reg. req.)

> The French in vitro diagnostics company bioMérieux has been nominated for the 2014 Prix Galien Award in the United States for its VITEK MS system, which uses mass spectrometry to rapidly identify disease-causing bacteria and yeast. Release

> Astute Medical is getting $30 million in funding from CRG that will fuel commercialization of the diagnostic NephroCheck Test System for acute kidney injury. Item

> RPS has raised $28 million in financing from OrbiMed to help globalize the use of its test for influenza-like conditions that could benefit from antibiotics. Story

> NanoLogix in Ohio said it is configuring its N-Assay Rapid diagnostic kits for Ebola virus detection and is seeking a corporate partner for the effort. Release

> Local hospitals in Minnesota are telling state Health Department officials that their in-house clinical laboratories don't want to perform certain routine blood tests on patients identified as possible Ebola cases. Story